Pierce, A. and Nester, T. (2011) Pathology Consultation on Drug-Induced Hemolytic Anemia. American Journal of Clinical Pathology, 136, 7-12.
https://doi.org/10.1309/AJCPBVLJZH6W6RQM

has been cited by the following article:

• TITLE: Drug-Induced Hemolytic Anemia: A Fatal Complication Further Under-Recognized in Sickle Cell Disease

  AUTHORS: Monica Khurana, Shekhar S. Raj

  KEYWORDS: Sickle Cell, Hemolytic Anemia, Blood Bank, Pathology

  JOURNAL NAME: Open Journal of Blood Diseases, Vol.7 No.3, September 25, 2017

  ABSTRACT: Drug-induced immune hemolytic anemia (DIIHA) is commonly attributed to cephalosporins. Ceftriaxone is the most frequently administered cephalosporin in patients with sickle cell disease. We present a pediatric patient with severe DIIHA (hemoglobin